GE HealthCare has expanded its women’s health imaging portfolio with the launch of Invenia Automated Breast Ultrasound (ABUS) Prime and ABUS StreamVue, two solutions designed to improve supplemental breast cancer screening, streamline clinical workflows, and enable more flexible image review across healthcare facilities.
The new automated breast ultrasound system combines three-dimensional imaging capabilities with artificial intelligence (AI)-supported tools to help technologists capture consistent scans while assisting radiologists with efficient image interpretation. The launch comes as healthcare providers continue to seek advanced screening technologies that can support early cancer detection, particularly among women with dense breast tissue where traditional mammography may have limitations.
Breast imaging continues to evolve as healthcare systems focus on improving screening access, diagnostic accuracy, and workflow efficiency. Automated ultrasound technologies are gaining attention because they provide additional imaging information that can complement existing screening methods and help clinicians evaluate breast tissue in greater detail.
GE HealthCare’s latest platform is designed to address several operational challenges faced by breast imaging centers, including the need for standardized image acquisition, faster scanning processes, and remote collaboration between specialists. The company said the new solutions aim to support providers in delivering more consistent patient care while improving efficiency across imaging networks.
AI-Based Features Aim to Improve Imaging Consistency and Workflow Efficiency
The Invenia ABUS Prime system introduces multiple AI-powered features through GE HealthCare’s Verisound AI platform. These tools are designed to support technologists during examinations by helping maintain consistent scan quality and improving the reproducibility of three-dimensional ultrasound images.
One of the key features of the system is automated scan quality assessment, which helps identify whether captured images meet quality standards. The platform also includes auto nipple detection technology, reducing manual adjustments during the scanning process and supporting a more streamlined examination experience.
GE HealthCare stated that its Fast Scan feature can improve scanning speed by up to 40% compared with the previous Invenia ABUS 2.0 system. Faster image acquisition could help breast imaging centers manage growing screening volumes while maintaining consistent examination quality.
The system also incorporates a redesigned transducer and adjustable compression settings aimed at improving patient comfort during procedures. Patient experience has become an increasingly important consideration in diagnostic imaging, as discomfort during examinations can influence screening participation and adherence.
Invenia ABUS Prime has received U.S. Food and Drug Administration (FDA) premarket approval and carries CE marking, allowing the technology to be used in markets that recognize European conformity standards.
Alongside the automated ultrasound system, GE HealthCare introduced ABUS StreamVue, a browser-based image viewing platform designed to provide radiologists with remote access to ABUS examinations. The solution allows clinicians to review breast ultrasound studies across enterprise imaging networks and multiple breast imaging locations.
The cloud-enabled approach is intended to make image access easier for healthcare organizations with distributed facilities. Radiologists can compare examinations performed at different locations while reducing challenges associated with traditional image-sharing processes.
GE HealthCare said the platform is designed with simplified installation and maintenance requirements, helping healthcare providers integrate the technology into existing imaging environments. Candelis worked with GE HealthCare to support the development of StreamVue technology for use with Invenia ABUS systems.
GE HealthCare Expands Role in Next-Generation Breast Cancer Screening Technologies
The introduction of Invenia ABUS Prime and ABUS StreamVue reflects a broader industry movement toward combining imaging innovation, automation, and artificial intelligence to improve diagnostic workflows.
The company’s Invenia platform also supports QVCAD, an AI-assisted reading solution designed to highlight areas that may require additional review. By assisting radiologists in identifying potential abnormalities, such technologies aim to reduce interpretation workload and support more efficient clinical decision-making.
Healthcare providers are increasingly exploring AI-assisted imaging tools as screening demand rises and radiology departments face workforce pressures. However, industry experts continue to emphasize that these technologies are intended to support clinicians rather than replace physician expertise.
The first U.S. installation of Invenia ABUS Prime was completed at BeSound, a breast imaging provider in Los Angeles. The organization is also developing a mobile screening unit designed to expand access to supplemental breast imaging services for patients in different communities.
Mobile imaging programs have gained interest as healthcare systems attempt to address geographic barriers and improve preventive care access. By combining advanced imaging systems with mobile healthcare models, providers may be able to reach more individuals who face challenges accessing traditional screening facilities.
Karley Yoder, CEO of Ultrasound Solutions at GE HealthCare, said the new system is designed to support more streamlined workflows and reproducible imaging while helping clinicians deliver improved patient care.
The launch strengthens GE HealthCare’s position in the growing breast imaging market, where demand for supplemental screening solutions continues to rise. As healthcare providers focus on earlier cancer detection and personalized screening approaches, technologies that improve image quality, workflow efficiency, and access to specialist review are expected to play an increasingly important role.
With the combination of automated ultrasound imaging, AI-supported acquisition tools, and remote reading capabilities, GE HealthCare’s latest solutions represent a shift toward more connected and efficient breast cancer screening environments. The company’s expansion into advanced breast imaging technologies highlights the growing importance of digital tools in supporting early diagnosis and improving outcomes for patients worldwide.
Ref: https://www.mobihealthnews.com/news/ge-healthcare-launches-ai-breast-ultrasound-system-remote-viewer
